Nevertheless, considering the firm association between p53 mutation and tumor metastasis and resistance to chemotherapy or radiotherapy, the newly found miR–iASPP interaction may well enlighten us with novel directions in dealing with these problems in the near future. The gene discussed is TP53; the disease is neoplasm.